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Abstract
Background: The proteome of mitochondria comprises mostly proteins that originate as precursors in the cytosol.
Before import into the organelle, such proteins are exposed to cytosolic quality control mechanisms. Multiple lines
of evidence indicate a significant contribution of the major cytosolic protein degradation machinery, the ubiquitin-
proteasome system, to the quality control of mitochondrial proteins. Proteins that are directed to the mitochondrial
intermembrane space (IMS) exemplify an entire class of mitochondrial proteins regulated by proteasomal
degradation. However, little is known about how these proteins are selected for degradation.
Results: The present study revealed the heterogeneous cytosolic stability of IMS proteins. Using a screening approach,
we found that different cytosolic factors are responsible for the degradation of specific IMS proteins, with no single
common factor involved in the degradation of all IMS proteins. We found that the Cox12 protein is rapidly degraded
when localized to the cytosol, thus providing a sensitive experimental model. Using Cox12, we found that lysine
residues but not conserved cysteine residues are among the degron features important for protein ubiquitination. We
observed the redundancy of ubiquitination components, with significant roles of Ubc4 E2 ubiquitin-conjugating
enzyme and Rsp5 E3 ubiquitin ligase. The amount of ubiquitinated Cox12 was inversely related to mitochondrial
import efficiency. Importantly, we found that precursor protein ubiquitination blocks its import into mitochondria.
Conclusions: The present study confirms the involvement of ubiquitin-proteasome system in the quality control of
mitochondrial IMS proteins in the cytosol. Notably, ubiquitination of IMS proteins prohibits their import into
mitochondria. Therefore, ubiquitination directly affects the availability of precursor proteins for organelle
biogenesis. Importantly, despite their structural similarities, IMS proteins are not selected for degradation in a
uniform way. Instead, specific IMS proteins rely on discrete components of the ubiquitination machinery to
mediate their clearance by the proteasome.
Keywords: Ubiquitination, Protein import, Protein degradation, Proteasome, Mitochondria, Intermembrane
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Background
Cellular protein synthesis by cytosolic ribosomes is a start-
ing point of complex protein logistics. More than 50% of
newly synthesized proteins need to be transported to their
specific destinations from the site of their synthesis. Many
specialized transport pathways cooperate to guarantee the
precise distribution and maturation of proteins. Simultan-
eously, quality control pathways guard the process of pro-
tein transport and folding. Such quality control
mechanisms react to the mislocalization or misfolding of
proteins, with the goal of minimizing their deleterious
effects on cellular function [1–3]. The requirement for so-
phisticated transport and quality control machinery is
apparent for cellular organelles with well-defined bound-
aries. This is the case for mitochondria, which are essen-
tial organelles of eukaryotic cells that are the site for
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energy-converting oxidative phosphorylation, various ana-
bolic and catabolic processes (e.g., amino acid and lipid
metabolism), the production of iron-sulfur clusters, and
are an integral part of cellular ion homeostasis and cellular
signaling networks [4–8]. Mitochondria are defined by
two membranes—mitochondrial outer membrane (OM)
and mitochondrial inner membrane (IM)—that surround
two distinct aqueous compartments: the intermembrane
space (IMS) and the mitochondrial matrix [7, 9, 10]. To
perform their functions, mitochondria need a specialized
array of proteins. The best-characterized mitochondrial
proteomes of the yeast Saccharomyces cerevisiae and
humans contain 900–1500 different proteins [11–13]. The
bulk of mitochondrial proteins is encoded by the nuclear
genome, and these proteins are produced by cytosolic ri-
bosomes. Such mitochondrial precursor proteins can con-
stitute up to 15% of all proteins that are produced in the
cytosol and require active transport into the organelle. To
ensure accurate precursor protein targeting and proper
maturation, several sorting and assembly pathways
cooperate [14–20]. The first step of import, which is com-
mon to nearly all mitochondrial proteins, is crossing the
mitochondrial OM by the translocase of the outer mem-
brane (TOM) multi-subunit complex. After crossing the
OM, proteins are routed further with their final destina-
tions encoded in their amino acid sequence. Many pro-
teins of the IMS follow the mitochondrial import and
assembly (MIA) pathway, which combines protein import
with oxidative folding. Mitochondria contain pathways to
refold misfolded proteins or degrade damaged ones, thus
providing quality control mechanisms for proteins that
enter the organelle [21, 22]. Protein import into the
mitochondria is in part co-translational [23–25]. However,
the import of most mitochondrial precursor proteins
can occur as a post-translational process. Such
post-translationally imported precursors, from the
time of their synthesis until they enter the mitochon-
drial compartment, are under the control of cytosolic
quality control mechanisms [26]. These quality con-
trol mechanisms are crucial because the accumulation
of unimported mitochondrial proteins severely im-
pacts cellular protein homeostasis [27, 28]. When
mitochondrial precursor proteins are mislocalized to
the cytosol, they can initiate the reprogramming of
cellular protein turnover. Cytosolic translation be-
comes constricted, and protein clearance is enhanced
by an increase in assembly and activity of the prote-
asome [3, 28]. The proteasome is the major cytosolic
machinery that degrades individual proteins. Several
studies found that proteins that are destined to mito-
chondria are degraded by the proteasome both when
import is defective and under physiological conditions
[29–33]. Previously, we identified an entire group of
mitochondrial proteins (i.e., clients of the MIA import
pathway in the IMS) as substrates of the proteasome
[31]. Proteasome-mediated degradation provides a
surveillance mechanism for these IMS proteins and
prevents their accumulation in an incorrect compart-
ment. Notably, proteasomal degradation is not limited
to situations in which protein import into mitochon-
dria fails. A portion of IMS proteins is also continu-
ously removed under physiological conditions when
import machinery is fully functional. Thus, the prote-
asome adjusts the availability of IMS precursor pro-
teins, directly affecting mitochondrial biogenesis [31].
Reaching the final location is one step in the matur-
ation of mitochondrial proteins that must be accom-
panied by their proper folding. Damaged IMS
proteins can be degraded within the organelle [30,
34–36]. However, unfolded proteins of the mitochon-
drial IMS can retro-translocate to the cytosol, thus
becoming re-exposed to the proteasome [37].
Although the involvement of proteasomal degradation
in shaping the IMS proteome is well evidenced, the
exact mechanisms that govern this process remain
obscure.
Proteins are marked for proteasomal degradation by
the covalent attachment of ubiquitin [38–41]. Polyubi-
quitin chains are frequently built on the substrate, but
even the attachment of a single ubiquitin can serve as a
sufficient signal for the proteasomal degradation of small
proteins [42]. Ubiquitination requires the concerted ac-
tion of three types of enzymes. Ubiquitin is first
activated by a ubiquitin-activating E1 enzyme and trans-
ferred to a ubiquitin-conjugating E2 enzyme. Subse-
quently, the E2 enzyme partners with an E3 ubiquitin
ligase to conjugate ubiquitin to the recipient protein. E3
ubiquitin ligases form a large and diverse group. The
diversity of E3 proteins is necessary because they serve
as receptors for a broad range of substrates, thus provid-
ing specificity to the ubiquitination process. Ubiquitina-
tion signals can be removed by the antagonistic activity
of deubiquitinating enzymes (DUBs), forming an add-
itional level of control [43, 44]. We previously found that
IMS proteins are ubiquitinated in vivo [31]. A better un-
derstanding of the mechanisms of IMS protein-specific
degradation by the ubiquitin-proteasome system
requires the identification of regulatory proteins that
mediate this process. Specific features within a substrate
protein provide internal signals, termed “degrons”, that
determine recognition by E3 ubiquitin ligases and modu-
late degradation efficiency [45–47]. Many precursor pro-
teins that are targeted to the IMS and are the substrates
of the MIA pathway share a characteristic
helix-loop-helix domain (CHCHD) fold. In a mature
IMS-located protein, this fold is stabilized by disulfide
bonds that are formed between cysteine residues. Cyst-
eine residues that are involved in stabilizing the IMS
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protein structure are commonly arranged in evolutionar-
ily conserved CX3C or CX9C motifs [48–50]. Remaining
unknown, however, is whether common structural fea-
tures of IMS proteins are part of degrons that determine
their cytosolic turnover.
In summary, despite the clear involvement of the
ubiquitin-proteasome system in the quality control of
IMS proteins, little is known about the ways in which
these proteins are selected for degradation. To better
understand this process, we employed parallel ap-
proaches to monitor the cytosolic degradation of IMS
proteins. Using a screening approach, we identified com-
ponents of the ubiquitin-proteasome system that impact
the stability of these proteins. We also unveiled that IMS
proteins differ in their stability when exposed to the
cytosolic environment. The Cox12 protein was the most
rapidly degraded among the studied examples. We used
Cox12 to investigate the way in which its internal fea-
tures affect the ubiquitination process and turnover effi-
ciency. Finally, we deciphered the antagonistic
relationship of two processes: precursor protein import
to mitochondria and precursor protein ubiquitination.
Despite their structural similarities, we concluded that
proteins of the IMS do not share a common ubiquitina-
tion mechanism. Redundant pathways appear to provide
a ubiquitination signal that triggers proteasomal degrad-
ation. Importantly, ubiquitinated precursor proteins can-
not be imported into mitochondria. However, under
normal conditions, the import process outcompetes the
ubiquitination reaction, allowing most of the precursor
proteins to reach their destination within the organelle.
Results
Tandem fluorescent protein timer as a tool to investigate
degradation of IMS proteins in vivo
To compare the cytosolic stability of proteins that are
destined to the IMS, we employed tandem fluorescent
protein timer (tFT) fusions as a tool to monitor protein
turnover in vivo. In this approach, the protein of interest
is expressed as a fusion with two fluorescent proteins:
mCherry and superfolder green fluorescent protein
(sfGFP; Fig. 1a) [51]. Rapidly folding and maturing sfGFP
becomes fluorescent shortly after protein synthesis. In
contrast, mCherry requires a longer time to develop
fluorescence. The ratio of mCherry/sfGFP fluorescence
intensities decreases as the degradation rate of
mCherry-sfGFP fusions increases. A fraction of sfGFP
from the tFT resists proteasomal degradation while
mCherry is fully degraded [52]. This further decreases the
mCherry/sfGFP fluorescence ratio with increasing deg-
radation of the fusion protein [52]. The fluorescence of
both proteins can be easily measured in vivo to allow
direct comparisons. Any signals for degradation that are
present in the protein of interest affect the tFT readout.
Thus, the tFT that is fused to the C-terminus of a pro-
tein of interest allows the tracking of its degradation rate
[51, 52]. We prepared tFT fusions of selected IMS pro-
teins having either a CX9C motif (Cox12, Cox17, Mix17,
and Pet191) or a CX3C motif (Tim9 and Tim10). The
expression of such fusions did not affect the growth of a
wild-type yeast strain, similar to the tFT alone (Fig. 1b).
Next, we used confocal microscopy to monitor the sub-
cellular localization of tFT-tagged IMS proteins (Fig. 1c).
We used MitoTracker Deep Red FM dye as a marker for
mitochondria and calcofluor white to stain the cell wall.
Fluorescence signals of both sfGFP and mCherry were
present throughout the cytoplasm, with nearly perfect
co-localization of the two fluorophores as expected for
fusion proteins. None of the tested tFT fusions was
enriched within the cell areas that were stained with
MitoTracker. Instead, all tFT fusions presented a cyto-
plasmic distribution pattern that was very similar to the
tFT alone. This indicates that none of the tested IMS
proteins were effectively targeted to mitochondria when
they were tagged with the tFT. The lack of mitochon-
drial import of tFT-tagged MIA substrates can be likely
attributed to the size and fold of the tFT and the limited
import driving force [53, 54]. This assumption is sup-
ported by a genome-wide protein localization study in
yeast, based on gene tagging with GFP, that did not as-
sign MIA substrates to mitochondria, often indicating
their cytosolic localization [55]. Importantly, the cyto-
solic localization of fusion proteins increased their ex-
posure to the cytosolic quality control machinery. Next,
we measured mCherry/sfGFP fluorescence ratios of
tFT-tagged IMS proteins in vivo (Fig. 1d). We used the
tFT itself (i.e., not fused with any protein) as a control
because this fusion is highly stable within the cell [51].
We have also included three engineered tFT fusion pro-
teins with N-terminal degrons that represent different
rates of degradation dependent on the amino acid resi-
due exposed at their N-terminus (phenylalanine, isoleu-
cine, or methionine) [51, 56]. All tFT-tagged IMS
proteins exhibited lower mCherry/sfGFP fluorescence
ratios compared to the tFT alone. This indicates that all
tested IMS proteins destabilized the tFT construct. Inter-
estingly, the tested proteins differed broadly in their
turnover, with Cox12 exhibiting the lowest mCherry/
sfGFP ratio, indicating that this protein was the most
unstable. Fluorescence ratios of mCherry/sfGFP mea-
sured for Cox12-tFT were similar to those measured for
the most unstable control fusion with the phenylalanine
N-terminal degron. Next in the order of increasing sta-
bility were Pet191 and Tim9 with measured fluorescence
ratios comparable to the isoleucine N-terminal degron.
Remaining IMS proteins exhibited fluorescence ratios in
the range of the more stable N-degron tFT fusion with
N-terminal methionine residue (Tim10, Cox17, and
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Mix17, Fig. 1d). Different rates of the cytosolic turnover
of IMS proteins might indicate that signals for degrad-
ation that are present in these proteins differ with regard
to either quality or quantity.
Variant of Cox12 with mutated cysteine residues is a
viable model to study degradation in the cytosol
After determining that Cox12 was the most rapidly de-
graded IMS protein, we sought to examine its turnover
without the relatively large tFT tag. We developed an
assay based on the inducible overproduction of Cox12
tagged with a FLAG peptide (Cox12FLAG) followed by
cycloheximide (CHX) treatment to inhibit cytosolic pro-
tein synthesis (Fig. 2a). Under such conditions, Cox12-
FLAG was found to be relatively stable, with only a small
decrease in protein levels after 1 h of CHX treatment
(Fig. 2b, lanes 1–3). Thus, we sought to determine
whether import and folding affected the cytosolic
Fig. 1 Diverse cytosolic stability of IMS proteins revealed by the tandem fluorescent protein timer approach. a Schematic illustration of a tandem
fluorescent protein timer (tFT) fusion. The protein of interest is tagged with two fluorescent proteins with different maturation kinetics. The fluorescent
signal ratio of slowly maturing mCherry protein and the rapidly maturing sfGFP protein reflects the half-life of the entire protein fusion. b Tenfold
dilutions of WT cells that expressed the indicated plasmid-borne tFT fusions or an empty vector control were spotted on selective medium agar plates
with either glucose or glycerol as the main carbon source. c Live confocal imaging of WT cells that expressed the indicated plasmid-borne tFT fusions
and an empty vector control. Yeast were grown in minimal selective media with 3% glycerol at 24 °C. Prior to imaging, cells were
stained with MitoTracker Deep Red FM and calcofluor white to label mitochondria and the cell wall, respectively. d Ratio of mCherry and
sfGFP fluorescent signals measured in WT cells that expressed the indicated plasmid-borne tFT fusions. Cells were cultured in liquid selective media
with 2% glucose at 28 °C. The ratio for the tFT alone was set to 1. The data are expressed as mean ± SEM. n = 6. ev, empty vector; N-deg, N-terminal
degron; tFT, tandem fluorescent protein timer; WT, wild-type
Kowalski et al. BMC Biology  (2018) 16:66 Page 4 of 22
degradation of Cox12FLAG. The mitochondrial import
and folding of MIA pathway substrates require disulfide
bond formation [37, 48–50]. Thus, the reducing agent
dithiothreitol (DTT) was added to the cell culture in
parallel with CHX to inhibit oxidative folding. Our pre-
vious findings showed that treatment with a reducing
Fig. 2 Disturbance of Cox12 protein oxidative folding triggers its rapid proteasome-mediated degradation. a Schematic illustration of the cycloheximide
(CHX) chase experiments. b Degradation of Cox12FLAG with or without 5 mM DTT treatment, tested using CHX chase. DTT was added in parallel to CHX
as indicated. c Schematic representation of Cox12 protein with indicated positions of cysteine residues and disulfide bonds. d Growth test of WT and
Δcox12 yeast transformed with a plasmid that carried Cox12FLAG or Cox12C-FREE-FLAG under control of the galactose-inducible promoter or an empty
vector control. Tenfold dilutions were spotted on selective minimal medium plates with a carbon source as indicated and grown at 28 °C. e Import of
radiolabeled Cox12 or Cox12C-FREE into mitochondria isolated from WT cells. The incubation times are indicated. Pretreatment with 50 mM IA was used
as a negative control. f Degradation of Cox12FLAG and Cox12C-FREE-FLAG, tested using CHX chase with or without DTT. g mCherry/sfGFP fluorescent signal
ratio measured in WT cells that expressed plasmid-borne Cox12-tFT, Cox12C-FREE-tFT, and empty tFT. Cells were cultured in selective medium with
glucose at 28 °C. The fluorescence ratio for the empty tFT was set to 1. Data are expressed as mean ± SEM, n= 6. Cox12-tFT and empty tFT data are the
same as in Fig. 1d. h, i The degradation of Cox12FLAG (h) or Cox12C-FREE-FLAG (i) in WT or pre2-DAmP yeast, tested using CHX chase. In parallel to CHX,
5 mM DTT was added (h). b, f, h, i The plasmid-borne Cox12FLAG was expressed using the copper-inducible promoter; yeast were cultured in selective
medium with 2% glucose at 28 °C. Proteins were analyzed by SDS-PAGE and immunodetection (b, f, h, i) or autoradiography (e). CHX, cycloheximide;
DTT, dithiothreitol; ev, empty vector; IA, iodoacetamide; PK, proteinase K; WT, wild-type
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agent led to the retro-translocation of reduced proteins
from mitochondria. When CHX and DTT were applied
in parallel, we observed much faster degradation of
Cox12FLAG (Fig. 2b, lanes 4–6). Treatment with DTT
affects numerous aspects of cell functioning and might
alter ubiquitination machinery, which is also thiol-based.
Therefore, we developed an independent approach to
monitor the cytosolic degradation of Cox12. Cox12 con-
tains four cysteine residues that are arranged in two
CX9C motifs that form two disulfide bonds in the ma-
ture protein (Fig. 2c). To prevent the oxidative import
and folding of Cox12FLAG, we constructed the Cox12C--
FREE-FLAG mutant, in which all four cysteine residues
were changed to serine residues. Cox12 is required for
the assembly of cytochrome c oxidase. We tested
whether the expression of Cox12C-FREE-FLAG could res-
cue the inability of the Δcox12 mutant to grow on
respiratory media (Fig. 2d) [57]. Although non-mutated
Cox12FLAG could rescue the Δcox12 growth defect,
Δcox12 yeast expressing Cox12C-FREE-FLAG did not grow
on the respiratory media, similar to the empty vector
control. This suggests that Cox12C-FREE-FLAG is not func-
tional. Next, we investigated whether this lack of
function is accompanied by a mitochondrial import
defect as expected for this mutant. We employed an
in organello import assay. Non-mutated Cox12 was
effectively imported into isolated mitochondria in a
time-dependent manner (Fig. 2e, upper panel, lanes
1–3). In the case of non-mutated protein, we also
observed the formation of an import intermediate of
Cox12 and Mia40 that was bound via a disulfide
bond (Fig. 2e, see “non-reducing”), a characteristic of
many MIA substrates. Further validating the import
assay, Cox12 import was effectively blocked with
iodoacetamide (IA) pretreatment, which irreversibly
binds to cysteine residues and thus blocks the forma-
tion of disulfide bonds (Fig. 2e, lane 4). In contrast to
wild-type Cox12, we observed complete inhibition of
Cox12C-FREE import and no intermediate formation
with Mia40 (Fig. 2e, lanes 5–7). Therefore, we
confirmed that Cox12C-FREE cannot be imported into
mitochondria and thus is likely to accumulate in the
cytosol, resulting in its exposure to the
ubiquitin-proteasome system. We subjected the
mutant to a CHX chase experiment (Fig. 2f ). The
levels of Cox12C-FREE-FLAG compared with Cox12FLAG
were lower from the beginning of the experiment, al-
though the expression of both proteins was induced
for the same length of time (Fig. 2f, compare lanes 1
and 4). Moreover, in contrast to Cox12FLAG, its cyst-
eine residue-free variant was rapidly degraded (Fig. 2f ).
Degradation of Cox12C-FREE-FLAG was not further
affected by the addition of the reducing agent (Fig. 2f ).
To confirm that the rapid removal of the mutant
protein is caused by its mislocalization to the cytosol
and exclude the possibility of greater affinity of the
degradation machinery that is caused by the muta-
tions, we prepared a tFT fusion of Cox12C-FREE.
When we compared mCherry/sfGFP fluorescence ra-
tios of Cox12-tFT and Cox12C-FREE-tFT, we found a
higher ratio for the C-FREE mutant, suggesting that
the mutant degrades even slower than wild-type
Cox12 when both proteins are located in the cytosol
(Fig. 2g). Thus, the rapid degradation of Cox12C-FREE
can likely be attributed to its cytosolic mislocalization
and not to greater affinity to the degradation
machinery.
As reported previously, the degradation of Cox12 can
be mediated by the proteasome [31, 37]. We sought to
further validate that Cox12 is degraded by the prote-
asome in the cytosol. We compared the degradation rate
in a wild-type yeast strain and in the pre2-DAmP strain
that exhibits a decrease in proteasome activity [58]. In
the pre2-DAmP strain, we observed the stabilization of
both Cox12FLAG during reductant treatment and
Cox12C-FREE-FLAG (Fig. 2h, i). Thus, we established an
assay to monitor proteasome-mediated degradation of
Cox12 that depends on mislocalization of the protein to
the cytosol.
Lysine residues are required for Cox12 ubiquitination
Protein tagging by ubiquitin allows for specific routing
for degradation by the proteasome. Our previous results
showed that Cox12, among other IMS proteins, can be
ubiquitinated in vivo [31]. For a detailed investigation of
Cox12 ubiquitination, we performed an assay for the
affinity purification of ubiquitinated proteins (Fig. 3a).
This assay confirmed that Cox12 is ubiquitinated in vivo
(Fig. 3b, lane 8). We observed a strong band, the migra-
tion of which corresponded to the mass of Cox12FLAG
that was modified by one ubiquitin molecule, and add-
itional weak bands that likely represented the attach-
ment of more ubiquitin molecules. We detected
ubiquitinated species only when both 6His-tagged ubi-
quitin and Cox12FLAG were expressed simultaneously,
thus confirming the specificity of the assay. Ubiquitin is
typically attached to a lysine residue in the target protein
[39, 41]. Thus, we sought to determine whether lysine
residues are required for Cox12 ubiquitination. Cox12
contains seven lysine residues (Fig. 3c). We prepared a
Cox12K-FREE-FLAG mutant, in which all lysine residues
were changed to arginine residues. Importantly,
Cox12K-FREE-FLAG complemented the lack of native
Cox12 and enabled respiratory growth of the Δcox12
strain (Fig. 3d). This indicates that the mutant protein
can reach the IMS to perform its function. Next, we sub-
jected Cox12K-FREE-FLAG to the CHX chase experiment
in presence of DTT (Fig. 3e). In contrast to
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Fig. 3 (See legend on next page.)
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non-mutated Cox12FLAG, the levels of Cox12K-FREE-FLAG
remained stable after the inhibition of protein synthesis
(Fig. 3e, compare lanes 1–3 and 4–6). This supports the
notion that lysine residues are the site for Cox12 ubiqui-
tination and are required for its efficient removal by the
proteasome. We used affinity purification of
ubiquitin-conjugated species to test whether the
Cox12K-FREE-FLAG mutation prevents ubiquitination
(Fig. 3f ). We did not observe any bands that might rep-
resent ubiquitinated Cox12K-FREE-FLAG. Simultaneously,
we could detect ubiquitinated wild-type Cox12 FLAG
(Fig. 3f, compare lanes 5 and 6). To determine the spe-
cific site of ubiquitin attachment, we investigated the
conservation status of lysine residues among Cox12
from fungal species that are related to S. cerevisiae
(Fig. 3c). Three lysine residues (K25, K36, and K41) are
very conserved. Therefore, we tested whether any of
these lysine residues might be sufficient to allow Cox12
ubiquitination. Based on Cox12K-FREE-FLAG, we created
three mutants in which lysine residues were
re-introduced at positions 25, 36, and 41, respectively.
These Cox12 variants were tested for in vivo ubiquitina-
tion (Fig. 3g). The three mutants were efficiently
expressed. However, similar to Cox12K-FREE-FLAG, we did
not observe any ubiquitin conjugates. Thus, we estab-
lished that the restoration of a single lysine residue (K25,
K36, or K41) is insufficient to restore Cox12 protein
ubiquitination. We also subjected the Cox12 amino acid
sequence to in silico analysis with three different algo-
rithms that were designed to predict ubiquitination sites
(UbPred, CKSAAP_UBSITE, and UbiProber) [59–61].
All algorithms indicated a generally low probability of
Cox12 ubiquitination, likely because of the small size of
the protein. Despite this, all three algorithms indicated a
poorly conserved lysine residue at position 73 as the
most likely to be ubiquitinated. Thus, based on Cox12K--
FREE-FLAG, we prepared a mutant with a re-introduced ly-
sine residue at position 73. Also, in this case, we did not
observe accumulation of the ubiquitinated form of the
protein (Fig. 3h). One possibility is that other lysine resi-
dues that were not tested herein (i.e., at position K49,
K53, or K66) are required for Cox12 protein ubiquitina-
tion. Another possibility is that lysine residues not only
serve as the ubiquitination site but also are part of the
recognition site. Therefore, more than one lysine residue
may be required for Cox12 ubiquitination.
Various components of the ubiquitin-proteasome system
are engaged in the degradation of IMS proteins
To gain further insights into the degradation of IMS
proteins, we used a screening approach [62] to identify
the factors that are involved in the degradation of
tFT-tagged IMS proteins. Strains expressing IMS pro-
teins that were chromosomally tagged with the tFT were
crossed with an array of strains that carried mutations of
individual components of the ubiquitin-proteasome sys-
tem, including proteasome subunits, E2, E3, and DUB
enzymes (Additional file 1: Table S1). Of the 18 chromo-
somally tFT-tagged substrates of the MIA pathway that
were present in the tFT library, three (Cmc1, Mrp10,
and Tim9) were removed from the screen because of
growth/fluorescence defects when crossed with
ubiquitin-proteasome mutants [62]. For the remaining
15 IMS proteins, the impact of each mutation on the
stability of tFT fusions was examined with fluorescence
measurements of colonies that were grown on the solid
medium. We observed a diverse pattern of tFT re-
sponses that were specific to individual IMS proteins
(Fig. 4a, Additional file 1: Table S1). Diverse factors
appear to be responsible for the degradation of different
IMS proteins, and no single factor appears to be
involved in the degradation of all IMS proteins. Among
the tested IMS proteins, Cox19 and Cox12 were consist-
ently stabilized in mutants defective in proteasomal
function. For several other tFT-tagged IMS proteins
(Coa6, Mic19, Mix14, Mix17, Mix23, and Tim13), the
mCherry/sfGFP fluorescence ratio also increased when
the proteasomal function was perturbed but did not
(See figure on previous page.)
Fig. 3 Lysine residues are required for Cox12 ubiquitination and proteasomal degradation. a Experimental scheme of 6His-tagged ubiquitin affinity
purification. b Affinity purification of ubiquitinated Cox12FLAG via 6His-ubiquitin. c Amino acid residue frequencies in Cox12 proteins among the
selected fungal species. Amino acid numbering is according to S. cerevisiae protein. The data are presented in WebLogo format; cysteine and lysine
residues are marked with red and blue, respectively. Positions of lysine residues that are present in S. cerevisiae Cox12 are indicated. d Growth test of
WT and Δcox12 yeast transformed with a plasmid that carried Cox12FLAG or its mutant with all seven lysine residues mutated into arginine residues
(Cox12K-FREE-FLAG) under the control of the galactose-inducible promoter and an empty vector control. Tenfold dilutions were spotted on selective
minimal medium with a carbon source as indicated and grown at 28 °C. e Degradation of Cox12FLAG and Cox12K-FREE-FLAG, tested using CHX chase
experiments. The plasmid-borne Cox12FLAG or Cox12K-FREE-FLAG were expressed in WT cells using the copper-inducible promoter. Yeast were cultured in
selective medium with 2% glucose at 28 °C. Samples were collected at the indicated time points, starting from the addition of CHX and DTT. f Affinity
purification of ubiquitinated Cox12FLAG and Cox12K-FREE-FLAG via 6His-tagged ubiquitin. g Affinity purification of ubiquitinated Cox12FLAG, Cox12K-FREE-
FLAG, and Cox12K-FREE-FLAG variants with single lysine residues reintroduced at positions 25, 36, or 41. h Affinity purification of ubiquitinated Cox12FLAG or
its variant that possessed only a single lysine residue at position 73. b, f, g, h The plasmid-borne Cox12FLAG variants were expressed in WT cells under
control of the galactose-inducible promoter. Yeast were cultured in modified selective medium with 3% glycerol at 28 °C. b, e, f, g, h Proteins were
analyzed by SDS-PAGE and immunodetection. 6His-Ub, 6His-tagged ubiquitin; CHX, cycloheximide; DTT, dithiothreitol; ev, empty vector; WT, wild-type
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reach the threshold for significance (Fig. 4a). Proteaso-
mal mutants (mutants of Rpn10, Rpn11, and Rpt6) were
among those with the strongest stabilization of
Cox12-tFT (Fig. 4b). Importantly, Cox12-tFT was also
stabilized in the absence of the E2 ubiquitin-conjugating
enzyme Ubc4 and in the mutants of the E3 ubiquitin
ligase Rsp5 (Fig. 4b), suggesting that these two enzymes
are potential regulators of cytosolic Cox12 turnover.
To validate the screening results, we tested whether
components of the ubiquitination machinery (i.e., the E2
ubiquitin-conjugating enzyme Ubc4 and the E3 ubiqui-
tin ligase Rsp5) that were identified in the screen were
involved in Cox12 ubiquitination. We first compared the
levels of ubiquitinated Cox12FLAG in wild-type and
Δubc4 strains. When Cox12FLAG production was driven
by the GAL10 promoter, we observed lower levels of
both unmodified Cox12 and monoubiquitinated Cox12
in the Δubc4 strain compared to the wild-type (Fig. 5a).
Therefore, we used unmodified protein levels to
normalize the observed monoubiquitinated Cox12FLAG
species. The quantification of monoubiquitinated
Cox12FLAG in the eluate fractions that were normalized
to unmodified Cox12FLAG levels showed a ~ 30% reduc-
tion of the monoubiquitinated form in the Δubc4 strain
(Fig. 5a, right panel). We performed a similar experi-
ment using the CUP1 promoter to drive Cox12FLAG pro-
duction, which results in higher protein levels. In this
case, no difference in the levels of unmodified Cox12-
FLAG was observed in the load fraction (Fig. 5b, lanes 3
and 4). In the eluate fractions, we observed a clear
reduction of bands that represented poly- or
multi-ubiquitinated Cox12FLAG (Fig. 5b, lanes 7 and 8).
These results indicate the involvement of the E2
ubiquitin-conjugating enzyme Ubc4 in Cox12 ubiquiti-
nation, but its role is not essential for the process. We
also tested whether Ubc4 impacts the degradation of
Cox12 using CHX chase experiments (Fig. 5c, d). In the
Δubc4 yeast strain, we observed the clear stabilization of
both Cox12C-FREE-FLAG and DTT-treated Cox12FLAG.
These observations confirmed the important role of
Ubc4 in Cox12 degradation by the proteasome. We also
determined how the deletion of UBC4 affects native
Cox12 (Fig. 5e). The levels of native Cox12 increased in
total protein extracts from Δubc4 yeast compared with
the wild-type strain. At the same time, the control pro-
teins Sod2 and Pgk1 remained unaffected. Accumulation
of Cox12 was visible at all tested growth temperatures:
19, 28, and 37 °C. This experiment provided further evi-
dence for the involvement of Ubc4 in cytosolic degrad-
ation of Cox12.
Next, we investigated whether the E3 ubiquitin ligase
Rsp5 is also involved in Cox12 ubiquitination. We
employed an rsp5-19 temperature-sensitive mutant
strain [63, 64]. We first performed the purification of
ubiquitinated Cox12FLAG via 6His-ubiquitin in wild-type
and rsp5-19 genetic backgrounds (Fig. 5f ). We observed
similar levels of unmodified Cox12FLAG in the load frac-
tions. In the eluate fractions, a significant decrease in
the levels of both mono- and polyubiquitinated Cox12-
FLAG species was apparent in the rsp5-19 mutant (Fig. 5f,
compare lanes 7 and 8). This observation suggested the
substantial involvement of Rsp5 in the ubiquitination of
Cox12. However, we also observed lower levels of
6His-ubiquitin in the rsp5-19 mutant compared with the
Fig. 4 Screens for machinery involved in the degradation of IMS proteins. a Summary heat map of the screens for components of the ubiquitin-proteasome
system that are involved in the degradation of the indicated tFT-tagged IMS proteins. Changes in protein stability (z-scores) are color-coded from blue
(decrease) to red (increase). Only mutants that significantly affected the stability of at least one tFT-tagged protein (5% false discovery rate and |z-score| > 4)
are shown. b Volcano plot of the screen results with Cox12-tFT, with z-scores for changes in protein stability on the x-axis and the negative logarithm of
p values adjusted for multiple testing on the y-axis. 19S proteasome mutants are represented by filled circles
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wild-type strain in both the load and eluate fractions
(Fig. 5f, right panel). Lower levels of ubiquitin may have
contributed to the observed reduction of ubiquitinated
forms of Cox12. Next, we tested the involvement of
Rsp5 in Cox12 degradation using CHX chase experi-
ments (Fig. 5g, h). In the rsp5-19 mutant strain, we
observed the stabilization of both Cox12C-FREE-FLAG and
DTT-treated Cox12FLAG. These observations supported
the role of Rsp5 in Cox12 degradation by the prote-
asome. We also evaluated the levels of native Cox12 in
the rsp5-19 mutant (Fig. 5i). As opposed to the previous
results, we did not observe increased levels of native
Cox12 in the rsp5-19 mutant. Thus, Rsp5 deficiency in-
creased the accumulation of ectopically expressed Cox12
while the native protein was not significantly affected.
Import impairment leads to increased ubiquitination and
degradation of precursor proteins
Mitochondrial proteins that are synthesized in the cyto-
sol can be either imported into mitochondria or
degraded by the ubiquitin-proteasome system. The kin-
etics of these two processes determine the ultimate
abundance of mature proteins that accumulate in mito-
chondria. Under physiological conditions, protein import
has an advantage over protein degradation. Therefore,
the majority of precursor proteins can reach maturity
inside the organelle. However, when protein import was
blocked, we observed rapid degradation of Cox12
(Fig. 2b, f ) [31]. To gain further insights into mutual
relations of the protein import efficiency and protein
degradation, we prepared four mutants of Cox12FLAG in
which single cysteine residues were exchanged for serine
residues. We monitored protein levels after the induced
expression of these mutants in wild-type cells using the
GAL10 promoter (Fig. 6a). The cellular levels of these
four Cox12FLAG single cysteine residue variants were
lower compared with the non-mutated protein but
higher than Cox12C-FREE-FLAG, pointing towards the
intermediate stability of these mutants. Importantly, all
four single cysteine residue mutants of Cox12FLAG were
functional as they complemented the loss of Cox12 and
allowed for the respiratory growth of Δcox12 yeast
(Fig. 6b). This also indicates that there is no single spe-
cific cysteine residue in the Cox12 sequence that is
essential for its import into mitochondria. However,
removing any of the four cysteine residues prevents the
formation of one of the two disulfide bonds that are
present in mature Cox12 (Fig. 2c). We chose two mu-
tants (C27S and C37S) to test how disruption of each of
the two disulfide bonds affects import into mitochondria
(Fig. 6c). Both Cox12C27S and Cox12C37S were imported
~ 50% less efficiently compared with the non-mutated
protein (Fig. 6c, right panel). Additionally, higher levels
of the import intermediates with Mia40 were observed
for both mutants, indicating potential stalling during im-
port (Fig. 6c, bottom panel). Next, we investigated the
way in which less-efficient import affects the ubiquitina-
tion of these mutants. The quantification of
affinity-purified monoubiquitinated forms of Cox12FLAG
that were normalized to the levels of Cox12FLAG in the
load fractions revealed that Cox12C27S-FLAG and
Cox12C37S-FLAG mutants were 25–50% more ubiquitinated
compared with non-mutated protein (Fig. 6d). Thus,
slower protein import resulted in greater ubiquitination.
Consequently, we expected that import-incompetent
Cox12C-FREE-FLAG would be even more ubiquitinated. In-
deed, despite much lower levels of accumulated Cox12C--
FREE-FLAG compared with non-mutated Cox12FLAG, we
purified similar amounts of ubiquitinated forms of Cox12
protein (Fig. 6e). After quantification and normalization,
we estimated an almost tenfold increase in ubiquitination
for this import-defective form of the protein (Fig. 6e, right
panel).
Protein ubiquitination blocks its mitochondrial import
We sought to determine whether a ubiquitinated protein
can escape degradation by the proteasome by getting
imported into mitochondria. Proteins crossing the OM
(See figure on previous page.)
Fig. 5 Involvement of the E2 ubiquitin-conjugating enzyme Ubc4 and the E3 ubiquitin ligase Rsp5 in Cox12 ubiquitination and degradation. a, b
Affinity purification of ubiquitinated Cox12FLAG via 6His-Ub from WT or Δubc4 yeast cells. The plasmid-borne Cox12FLAG was expressed under the
control of a galactose-inducible promoter (a) or a copper-inducible promoter (b). Yeast were cultured at 28 °C in modified selective medium with 3%
glycerol (a) or 2% glucose (b). Monoubiquitinated Cox12FLAG levels were quantified and normalized to ubiquitin-free Cox12FLAG levels from the load
fractions (a). The level of normalized monoubiquitinated Cox12FLAG from WT yeast was set to 100%. Data are expressed as mean ± SEM. n = 3. c, d
Degradation of Cox12FLAG (c) or Cox12C-FREE-FLAG (d) in WT and Δubc4 yeast, tested using CHX chase. The plasmid-borne Cox12FLAG and Cox12C-FREE-
FLAG were expressed using the copper-inducible promoter. Yeast were cultured in selective medium with 2% glucose at 28 °C. e Cellular protein levels
in WT and Δubc4 yeast grown in minimal medium with 3% glycerol at indicated temperatures. f Affinity purification of ubiquitinated Cox12FLAG via
6His-Ub in WT and rsp5-19 yeast. The plasmid-borne Cox12FLAG was expressed under the control of the copper-inducible promoter. Yeast were
cultured in modified selective medium with 2% glucose at 37 °C. Degradation of Cox12FLAG (g) or Cox12C-FREE-FLAG (h) in WT and rsp5-19
yeast. The plasmid-borne Cox12FLAG or Cox12C-FREE-FLAG were expressed under the control of the copper-inducible promoter. Yeast were
cultured in selective medium with 2% glucose at 28 °C. c, d, g, h Samples were collected at the indicated time points, starting from the
addition of CHX. In c, g, 5 mM DTT was added in parallel to CHX. i Cellular protein levels in WT and rsp5-19 yeast grown in minimal
medium with 3% glycerol at indicated temperatures. Proteins were analyzed by SDS-PAGE and immunodetection (all panels). 6His-Ub,
6His-tagged ubiquitin; CHX, cycloheximide; DTT, dithiothreitol; WT, wild-type
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by the TOM translocase need to be largely unfolded
[65–67]. A reasonable assumption is that folded ubiqui-
tin may form spatial hindrance during protein transport
through protein-conducting channel formed by Tom40
and would require at least partial unfolding. For illus-
tration, we juxtaposed the three-dimensional
cross-section of the Tom40 protein model and the
ubiquitin structure (Fig. 7a) [66, 67]. The fully folded
ubiquitin is substantially wider than the opening of
the protein-conducting channel of Tom40. Consider-
ing the limited import-driving force of the MIA path-
way, we hypothesized that ubiquitinated Cox12
protein cannot pass through the channel and thus
cannot reach the mitochondrial IMS. To test this
hypothesis, we created a construct that contained a
head-to-tail fusion of Cox12 and ubiquitin. Such a
fusion differs from the native condition, in which ubi-
quitin would be attached to one of the Cox12 lysine
residues by the C-terminal glycine with an isopeptide
bond. However, this model protein reflects the size
restraints of natively monoubiquitinated Cox12 pro-
tein. In the in organello import experiment,
Cox12-ubiquitin fusion did not enter the mitochon-
dria, in contrast to the wild-type Cox12 (Fig. 7b,
compare lanes 1–3 and 8–10). Also, free ubiquitin,
which we tested in this experiment, did not present
any affinity to isolated mitochondria (Fig. 7b, lanes
12–14). This result is consistent with our hypothesis
that ubiquitination prevents the import of precursor
proteins into mitochondria.
Altogether, our results showed that slower protein
import into mitochondria leads to an increase in precur-
sor protein ubiquitination, and ubiquitinated proteins
cannot be imported into mitochondria. Both of these ob-
servations may explain the lower accumulation of Cox12
mutants with a partial import defect. We compared the
accumulation of Cox12FLAG variants under normal
growth conditions and in the presence of the prote-
asome inhibitor MG132 (Fig. 7c). The accumulation of
non-mutated Cox12FLAG protein was only slightly in-
creased by inhibition of the proteasome (Fig. 7c, lanes 1
and 2). At the same time, less effectively transported to
mitochondria Cox12FLAG mutants, in which one of the
cysteine residues was changed to a serine residue,
responded very strongly to proteasome inhibition
(Fig. 7c, lanes 3–10). The cellular levels of all of these
mutants were significantly lower compared with the
non-mutated protein under normal growth conditions
but strongly increased upon proteasome inhibition up to
the level of non-mutated protein. To test whether
similar accumulation rescue would be visible when pro-
tein ubiquitination is compromised, we expressed
Cox12C27S-FLAG and Cox12C37S-FLAG in wild-type and
Δubc4 mutant cells. We observed an increase in the
accumulation of mutant Cox12FLAG proteins in Δubc4
mutant cells, similar to proteasome inhibition (Fig. 7d).
Together, these results suggest direct competition be-
tween protein import to mitochondria and protein ubi-
quitination (Fig. 7e).
Discussion
Our previous studies identified proteins from the mito-
chondrial IMS as substrates of the cytosolic
ubiquitin-proteasome system, but determinants of this
process have remained unknown [31, 37]. The present
study conducted an in-depth analysis of the cytosolic
degradation of mitochondrial IMS proteins. We estab-
lished a tandem fluorescent protein timer technique to
monitor the cytosolic turnover of IMS proteins. Using
this tool, we unveiled that proteins that are destined to
the IMS differ in their stability while exposed to the
cytosolic environment. This can be attributed to the
varying affinity of IMS proteins to the ubiquitination
machinery or proteasome as well as import efficiencies.
Among the IMS proteins that were tested, Cox12 was
the most rapidly degraded in the cytosol. Thus, we used
Cox12 to decipher internal features that constitute the
degron of this protein. We considered the possibility
(See figure on previous page.)
Fig. 6 Less-efficient import to mitochondria results in increased protein ubiquitination and decreased cellular accumulation. a Cellular accumulation of
Cox12FLAG, Cox12C27S-FLAG, Cox12C37S-FLAG, Cox12C48S-FLAG, Cox12C59S-FLAG, and Cox12C-FREE-FLAG proteins in WT yeast. Yeast were cultured on selective
minimal medium supplemented with glycerol as a carbon source at 28 °C. The expression of plasmid-borne Cox12FLAG variants was driven by the
galactose-inducible promoter. To induce expression, the medium was supplemented with 0.5% galactose for 6 h. b Growth test of WT and Δcox12
yeast transformed with plasmids that carried Cox12FLAG or one of its single cysteine residue mutants (C27S, C37S, C48S, C59S) and an empty vector
control. Tenfold dilutions were spotted on selective minimal medium with a carbon source as indicated and grown at 28 °C. c Import of radiolabeled
Cox12, Cox12C27S-FLAG, or Cox12C37S-FLAG into mitochondria isolated from WT cells. Incubation times are indicated. Pretreatment with 50 mM IA was
used as a negative control. The results were quantified, and the amount of WT Cox12 that was imported during 27 min of incubation was set to 100%.
The data are expressed as mean ± SEM, n = 3. d, e Affinity purification of ubiquitinated Cox12FLAG and Cox12C27S-FLAG, Cox12C37S-FLAG (d), or Cox12C-
FREE-FLAG (e) from WT cells via 6His-Ub. Levels of monoubiquitinated Cox12FLAG variants were quantified and normalized to ubiquitin-free Cox12FLAG
variants from the load fractions. The ubiquitinated Cox12FLAG level was set to 100%. The data are expressed as mean ± SEM. n = 3. Yeast were cultured
in liquid modified selective medium with 3% glycerol at 28 °C, and plasmid-borne Cox12FLAG variants were expressed under the control
of the galactose-inducible promoter. Proteins were analyzed by SDS-PAGE and immunodetection (a, d, e) or autoradiography (c). 6His-Ub,
6His-tagged ubiquitin; ev, empty vector; IA, iodoacetamide; PK, proteinase K; WT, wild-type
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that ubiquitin is attached to cysteine residues of MIA
substrate proteins because such a non-canonical man-
ner of ubiquitination was reported for other proteins
[68, 69]. This was plausible because of the presence
of highly conserved cysteine residues in MIA sub-
strate proteins. In the cytosol, these cysteine residues
remain reduced and thus available for modification.
However, our results exclude the contribution of ubi-
quitination on cysteine residues to cytosolic turnover
of Cox12. A variant of Cox12 in which all of the cyst-
eine residues were changed to serine residues was still
efficiently ubiquitinated and processed by the prote-
asome. We also found that lysine residues were essen-
tial for Cox12 ubiquitination and degradation by the
proteasome. The Cox12 variant in which all of the
lysine residues were substituted by arginine residues
was not ubiquitinated and was significantly more
stable than the native protein variant. Thus, Cox12
ubiquitination occurred in a canonical way, but we
did not find a single lysine residue that would be suf-
ficient to sustain Cox12 ubiquitination. This could
indicate that lysine residues not only serve as ubiqui-
tination sites but also are a part of the sequence
motif that is recognized by ubiquitination machinery.
In such case, more than one lysine residue might be
required for Cox12 ubiquitination. Another explanation
could be that Cox12 is ubiquitinated on one of the lysine
residues with low evolutionary conservation.
Using a systematic screening approach, we uncovered
effects of various ubiquitin-proteasome system compo-
nents on the cytosolic stability of specific IMS proteins.
In particular, two proteins (Cox12 and Cox19) exhibited
marked changes in tFT fluorescence, indicating their
stabilization in proteasome deficient strains. For many
other IMS proteins, we observed a similar increase in
mCherry/sfGFP fluorescence ratios, albeit in a less
well-defined manner. This may be partially attributable
to the higher stability of these IMS proteins, because
rapid turnover might be a factor that increases the sensi-
tivity of tFT fusions. Moreover, the screens were per-
formed at 30 °C, a semi-restrictive temperature for the
temperature-sensitive mutants in proteasome subunits
(e.g., rpt6 and rpn11 mutants). Therefore, some prote-
asome substrates are likely not strongly affected in these
mutants in our screens. Surprisingly, despite the struc-
tural similarities of IMS proteins, no single universal fac-
tor is involved in the degradation of all IMS proteins.
Conversely, the screening results showed that diverse
ubiquitin-proteasome system components mediate the
degradation of specific IMS proteins. Importantly, we
verified the screening results for Cox12, confirming the
role of two components of ubiquitination machinery: E2
ubiquitin-conjugating enzyme Ubc4 and E3 ubiquitin
ligase Rsp5 [70, 71]. These two enzymes were previously
shown to cooperate with each other, thus supporting the
possibility of their joint action in Cox12 ubiquitination
[72–74]. Ubc4 was previously shown to be involved in
the cytosolic degradation of apo-iso-1-cytochrome c,
another protein that is directed to the IMS [32]. Rsp5
was also previously reported to be involved in maintain-
ing the mitochondrial proteome and to be recruited to
mitochondria upon stress stimuli [75–78]. The results of
our biochemical experiments confirmed the decrease in
the ubiquitination of Cox12 in yeast strains without the
UBC4 gene or with Rsp5 activity impaired by genetic
mutation (rsp5-19). However, in both cases, ubiquitina-
tion was abolished only partially. We also observed an
increase in the stability of overproduced FLAG-tagged
Cox12 in both mutant strains, but the levels of native
Cox12 protein were visibly affected only in the Δubc4
mutant. These observations suggest the redundancy of
ubiquitination components. The activity of Ubc4 was re-
ported to be partially redundant with its paralog Ubc5
[70, 73]. However, our screening results did not indicate
the involvement of Ubc5 in Cox12 degradation (Fig. 4a,
Additional file 1: Table S1). Thus, the partial reduction
of Cox12 ubiquitination in the Δubc4 strain can be
explained by the existence of other redundant E2
ubiquitin-conjugating enzymes. Similarly, the fact that
we observed an increase in the accumulation of native
Cox12 protein in Δubc4 but not in the rsp5-19 mutant
can indicate that E3 ubiquitin ligases are also redundant.
Another possible explanation is that dependence on
Rsp5 is connected with prolonged exposure of Cox12 to
(See figure on previous page.)
Fig. 7 Cox12 protein ubiquitination prevents its import into mitochondria. a Juxtaposition of the three-dimensional density map of ubiquitin [PDB:1UBQ
structure] and cross-section of the three-dimensional density map of the Tom40 protein-conducting channel based on homology modeling. b Import of
radiolabeled Cox12, Cox12 head-to-tail fusion with ubiquitin (Cox12-Ub), and ubiquitin (Ub) into the mitochondria isolated from WT cells. The incubation
times are indicated. Pretreatment with 50 mM IA was used as a negative control for MIA-dependent import. c Cellular accumulation of Cox12FLAG,
Cox12C27S-FLAG, Cox12C37S-FLAG, Cox12C48S-FLAG, and Cox12C59S-FLAG proteins in WT yeast with or without MG132 proteasome inhibitor treatment. Yeast
were cultured in liquid modified selective medium with 3% glycerol at 28 °C; plasmid-borne Cox12FLAG variants were expressed under the control of the
galactose-inducible promoter. d Cellular accumulation of Cox12C27S-FLAG or Cox12C37S-FLAG proteins in WT and Δubc4 yeast. Yeast were cultured in liquid
selective medium with 3% glycerol at 28 °C; plasmid-borne Cox12FLAG variants were expressed under the control of the galactose-inducible promoter.
e Mitochondrial import of precursors of MIA substrate proteins is sensitive to ubiquitination. Ubiquitinated precursor proteins are rerouted from the
mitochondrial import pathway to proteasomal degradation. Proteins were analyzed by SDS-PAGE and autoradiography (b) or immunodetection (c, d). IA,
iodoacetamide; PK, proteinase K; Ub, ubiquitin; WT, wild-type
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the cytosolic environment that results from expression
of tagged protein from the plasmid. Notably, Cox12 does
not contain a PY motif that is characteristic of client
proteins that directly interact with Rsp5 ligase [79].
Thus, an additional adaptor protein that bridges Cox12
and E3 ubiquitin ligase is likely involved in the ubiquitin
conjugation process. Not all such adaptor proteins were
included in our screening approach and may require fur-
ther investigation. For some IMS proteins, redundancy
between different ubiquitination pathways could explain
the observed lack of stabilization in any single UPS
mutant.
Our screening results and the observed wide stability
spectrum of IMS protein tFT fusions indicate that these
proteins contain different and specific signals for degrad-
ation (i.e., degrons). Thus, we could reject the hypothesis
that common features of MIA substrate proteins (i.e.,
conserved cysteine residues motifs within α-helix re-
gions) may serve as shared, universal recognition traits
for E3 ubiquitin ligase. Instead, our results indicate that
IMS proteins rely on various recognition components
that are responsible for their ubiquitination. Importantly,
our protein turnover measurements rely on tFT fusions
with independent evidence only for Cox12. Thus, further
studies would be needed to verify if tagging with tFT in-
fluenced IMS proteins stability.
Another important issue is the way in which the
ubiquitination of mitochondrial precursor proteins
affects their import into the organelle. Mitochondrial
proteins comprise a substantial part of the cellular
ubiquitin-conjugated proteome [80]. Such ubiquiti-
nated proteins can localize to mitochondria, and some
were found localized inside the organelle [81, 82]. A
recent report described a case of ubiquitination in the
mitochondrial matrix, but free ubiquitin was not
detected in isolated mitochondria [82]. Our results
also demonstrate that free ubiquitin is not imported
into isolated mitochondria or does not bind to the or-
ganelle surface. Importantly, proteins need to be
largely unfolded to pass the TOM translocase,
because most folded domains would not fit into the
protein-conducting channel formed by Tom40 [65–
67]. This is also the case for IMS proteins which once
folded cannot traverse Tom40 translocase [37, 83].
Ubiquitin folds very stably, and a large pulling force
is required for its mechanical unfolding [84]. Presum-
ably, protein import into the matrix that is driven by
ATP hydrolyzing PAM motor would provide sufficient
energy to unfold ubiquitin conjugated to the precur-
sor protein in transit. However, import via the MIA
pathway is initially based only on the affinity of pre-
cursor proteins to the import machinery [36, 53, 54].
Given the limited driving force of IMS protein im-
port, we assumed that even a single ubiquitin
attached to the precursor would block its mitochon-
drial import, similar to the observed for tFT fusions.
Our results confirmed this hypothesis with lack of
mitochondrial import of Cox12-ubiquitin fusion. The
import defect could not be attributed to simple size
increase of the precursor protein as our previous re-
sults indicate that doubling the size of MIA substrate
protein did not affect its import into mitochondria
[37]. Thus, it is fair to assume that lack of import
was a result of ubiquitin fold. Remaining unclear is
whether the spatial hindrance that is formed by ubi-
quitin is a sole cause of import blockade or whether
an additional mechanism prevents the import of ubi-
quitinated proteins, similar to the mechanism that
was recently proposed for IM integral proteins [33].
We previously proposed that the proteasome regu-
lates the composition of the IMS proteome. The
present study broadens this observation to include
also protein ubiquitination which was shown to dir-
ectly affect the ability of the precursor protein to be
imported into the organelle. Mitochondrial protein
import via the MIA pathway is likely slower than im-
port via the TIM23 translocase [85]. Still, under nor-
mal conditions, import of MIA substrates appears to
have a kinetic advantage over the ubiquitination
process, and only a minor portion of precursor pro-
teins becomes ubiquitinated. However, with the de-
creasing efficiency of protein import, more precursor
proteins may become ubiquitinated and thus rerouted
from the import pathway to proteasomal degradation.
Evidence of a tight connection between mitochondria
and the ubiquitin-proteasome system is increasing,
and our mechanistic understanding of the interplay
between these two cellular systems continues to ad-
vance. Nonetheless, there are still unanswered ques-
tions. Most of our current analyses were based on
Cox12 protein and its derivatives. Our results indicate
that different IMS proteins can be tagged for degrad-
ation by separate ubiquitination components. Also,
the internal features of IMS proteins that affect their
degradation (i.e., degrons) are likely distinct. Thus,
some of the observations that were made for Cox12
may be specific to this protein. However, effective im-
port blockade that was caused by precursor protein
modification with ubiquitin is likely universal to other
MIA substrate proteins of the IMS and should be
considered as a contributor to mitochondrial protein
homeostasis.
Conclusions
Altogether, our results substantiate the role of the
ubiquitin-proteasome system in the regulation and
quality control of mitochondrial IMS proteins. Not-
ably, ubiquitination not only provides the signal
Kowalski et al. BMC Biology  (2018) 16:66 Page 16 of 22
targeting IMS proteins for degradation by the prote-
asome but also directly prohibits their mitochondrial
import. Therefore, ubiquitination limits the availability
of precursor proteins for organelle biogenesis.
Remarkably, common sequence motifs that are char-
acteristic for the substrates of the MIA import path-
way do not constitute universal degron recognized by
the cytosolic protein degradation machinery. Instead,
individual proteins must contain specific signals for
degradation as they rely on discrete components of
the ubiquitination machinery to mediate their
clearance.
Methods
Yeast strains, culture conditions, and plasmids
The Saccharomyces cerevisiae strains that were used in
this study are listed in Table 1. Yeast were grown in full
YPD or YPG media (1% yeast extract, 2% peptone, and
2% glucose or 3% glycerol, respectively) or in minimal
media that contained 0.5% ammonium sulfate and 0.17%
yeast nitrogen base, supplemented with suitable nutri-
ents and a carbon source as indicated. For proteasome
inhibition with MG132 (75 μM), the modified minimal
medium without ammonium sulfate but with 0.1% pro-
line and 0.003% sodium dodecyl sulfate (SDS) was used
as described previously [31]. To induce the GAL10 pro-
moter in liquid culture, 0.5% galactose was added. To
induce the CUP1 promoter, 100 μM CuSO4 was added.
To block protein synthesis, the cultures were supple-
mented with CHX to a final concentration of 100 μg/ml.
Where indicated, 5 mM DTT was added in parallel with
CHX to interfere with oxidative protein folding. Samples
were collected after the indicated incubation times and
flash frozen until preparation of total protein extracts
that were subjected to further analysis. Plasmids that
were used to express the proteins of interest are listed in
Table 2. Yeast cells were transformed according to a
standard procedure. For the growth test, selective min-
imal medium that contained 2.5% (w/v) agar was used.
Where indicated, the addition of 0.2% galactose was
used to induce the expression of proteins under control
of the GAL10 promoter.
Purification of ubiquitinated proteins via 6His-tagged
ubiquitin
Yeast were transformed with plasmids that encoded
6His-tagged ubiquitin (6His-Ub) and Cox12FLAG (or Cox12-
FLAG variants as indicated). Corresponding empty vectors
were used as controls. GAL10 or CUP1 promoters were
used to express Cox12FLAG. The CUP1 promoter was also
used to express 6His-UB. In experiments in which Cox12-
FLAG expression was driven by the GAL10 promoter, yeast
were grown in selective modified minimal medium without
ammonium sulfate supplemented with 0.1% proline and
0.003% SDS, with glycerol as a carbon source at 28 °C or as
indicated. For the final 6 h of growth, the yeast were
collected by centrifugation (5 min at 3000×g) and resus-
pended in a small volume of media with galactose (0.5% w/
v), CuSO4 (100 μM), and MG132 (75 μM) added. In the
experiments in which Cox12FLAG expression was driven by
the CUP1 promoter, yeast were grown in selective modified
minimal medium without ammonium sulfate with glucose
as a carbon source at 28 °C until the mid-log phase was
reached. For the final 1 h, the yeast were collected by centri-
fugation (5 min at 3000×g) and resuspended in a small vol-
ume of media. CuSO4 (100 μM) and MG132 (75 μM) were
added to the medium, and the cells were incubated at 28 or
37 °C. The cells were harvested by centrifugation for 3 min
at 20,000×g. Cell pellets were then resuspended in denatur-
ing lysis buffer (6 M guanidine hydrochloride, 100 mM KPi
[pH 8.0], 10 mM Tris-HCl [pH 8.0], 50 mM iodoacetamide,
5 mM imidazole, 0.1% Triton X-100, 2 mM PSMF, and
75 μM MG132) and disrupted by 15 min of vortexing with
glass beads. The solution was clarified by centrifugation for
10 min at 20,000×g, and the supernatant was moved to a
new tube. Before the addition of nickel-nitrilotriacetic acid
(Ni-NTA) agarose beads (Qiagen), load fractions were col-
lected from the samples. The samples were incubated with
Ni-NTA for 2 h at room temperature with gentle mixing.
After centrifugation for 2 min at 200×g, the supernatant was
removed from Ni-NTA beads. Unbound fractions were col-
lected, and Ni-NTA beads were washed once with lysis buf-
fer and three times with wash buffer (8 M urea, 100 mM
KPi [pH 6.4], and 10 mM Tris-HCl [pH 6.4]). Purified pro-
teins were eluted at 65 °C with 2× Laemmli buffer (4% SDS,
Table 1 Yeast strains used in this study
Strain (lab ID no.) Genotype Reference
YPH499 (524) MATa, ade2-101, his3-Δ200, leu2-Δ1, ura3-52, trp1-Δ63, lys2-801 [101]
BY4741 (755) MATa, his3Δ 1, leu2Δ 0, met15Δ 0, ura3Δ 0 Euroscarf
Δcox12 (722) MATa, his3Δ 1, leu2Δ 0, met15Δ 0, ura3Δ 0, YLR038c::kanMX4 Euroscarf
Δubc4 (1007) MATa, his3Δ 1, leu2Δ 0, met15Δ 0, ura3Δ 0, YBR082C::kanMX4 Open Biosystems
pre2-DAmP (1051) MATa, his3Δ 1, leu2Δ 0, met15Δ 0, ura3Δ 0, YPR103W::YPR103W-DAmP-kanMX4 Dharmacon
MHY501 (794) MATα his3-Δ200 leu2-3112 ura3-52 lys2-801 trp1-1 [102]
rsp5-19 (796) MATα his3-Δ200 leu2-3112 ura3-52 lys2-801 trp1-1, rsp5::rsp5-19 (P418L) [63]
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20% glycerol, 125 mM Tris-HCl [pH 6.8], and 0.02% bromo-
phenol blue) supplemented with 100 mM DTT. Load and
unbound samples were precipitated with 10% trichloroacetic
acid (TCA), washed with acetone, air dried, and resus-
pended with 2× Laemmli buffer supplemented with
100 mM DTT. All of the samples were denatured at 65 °C.
Import of radiolabeled proteins into isolated
mitochondria
Mitochondria were isolated from wild-type cells that
were grown in YPG medium at 24 °C. A standard proto-
col of the isolation by differential centrifugation was
used [86]. Crude mitochondrial pellets were suspended
in SM buffer (250 mM sucrose and 10 mM
3-morpholinopropane-1-sulfonic acid [MOPS]-KOH
[pH 7.2]). Protein content was measured using the Brad-
ford assay, and the concentration was adjusted to 10 mg
of protein/ml. Isolated mitochondria were stored frozen
at − 80 °C. For mRNA synthesis, the mMESSAGE
mMACHINE SP6 Transcription Kit (Invitrogen) was
used. For the synthesis of [35S]methionine-labeled pro-
teins, the Flexi rabbit reticulocyte lysate translation
system (Promega) or TNT quick coupled transcription/
translation system (Promega) was used in accordance
with the manufacturer’s protocols. At the end of the
translation reactions, proteins were precipitated with
ammonium sulfate and resuspended in urea buffer (8 M
urea, 30 mM MOPS-KOH [pH 7.2], and 10 mM DTT).
Radiolabeled proteins were incubated with isolated mito-
chondria in the import buffer (250 mM sucrose, 5 mM
MgCl2, 80 mM KCl, 10 mM MOPS-KOH, 5 mM me-
thionine, and 10 mM KH2PO4 [pH 7.2] supplemented
with 2 mM ATP and 2 mM NADH) at 25 °C for the
indicated time. Radiolabeled proteins comprised 2% of
the import reaction mixture. Resulting dilution of urea
allows for rapid self-folding of ubiquitin while Cox12
folding requires Mia40 assistance in the IMS [48–50,
87]. Import reactions were stopped by placing the sam-
ples on ice and adding IA to a final concentration of
50 mM. Where indicated, to remove non-imported pro-
teins, the samples were treated with 10 μg/ml proteinase
K on ice for 15 min. Protease digestion was stopped by
the addition of phenylmethylsulfonyl fluoride (PMSF) to
a final concentration of 2 mM. Mitochondria were then
reisolated by centrifugation for 10 min at 20,000×g and
washed with SM buffer supplemented with 2 mM PMSF.
Finally, the samples were dissolved in 2× Laemmli buffer
with the addition of 100 mM DTT or 50 mM IA for
reducing and non-reducing SDS-polyacrylamide gel elec-
trophoresis (PAGE), respectively. Radiolabeled proteins
were detected by digital autoradiography using Storage
Phosphor screens (GE Healthcare) and Typhoon TRIO+
Variable Mode Imager (GE Healthcare).
Screens for factors involved in the degradation of tFT-
tagged proteins
Query strains that expressed IMS proteins that were
endogenously tagged with the mCherry-sfGFP timer
were obtained from the tFT library [62]. Screens were
performed essentially as described previously [62].
Briefly, the screens were conducted in 1536-colony for-
mat, with four technical replicates that were arranged
next to each other on agar plates. Using synthetic
genetic array methodology [88], each query strain was
crossed to an array of haploid strains carrying knock-
out [89], temperature-sensitive (ts) [90], or DAmP
[91] alleles of individual components of the
ubiquitin-proteasome system. The selection of dip-
loids, sporulation, and the selection of haploids that
Table 2 Plasmids used in this study








pLK1 (589) pRS425-CUP1PR-6His-Ub This study
pESC-URA pESC-URA Agilent
pAG3 (55) pESC-URA-GAL10PR-Cox12FLAG [31]
pPB36.1 (471) pESC-URA-CUP1PR-Cox12FLAG This study
pEG1 (103) pESC-URA-GAL10PR-Cox12C27S-FLAG This study
pEG2 (104) pESC-URA-GAL10PR-Cox12C37S-FLAG This study
pEG3 (105) pESC-URA-GAL10PR-Cox12C48S-FLAG This study
pEG4 (106) pESC-URA-GAL10PR-Cox12C59S-FLAG This study
pLK2 (590) pESC-URA-GAL10PR-Cox12C-FREE-FLAG This study
pPB37.1 (472) pESC-URA-CUP1PR-Cox12C-FREE-FLAG This study
pPB32 (467) pESC-URA-GAL10PR-Cox12K-FREE-FLAG This study
pPB40.1 (613) pESC-URA-CUP1PR-Cox12K-FREE-FLAG This study
pLK3 (591) pESC-URA-GAL10PR-Cox12K25-FLAG This study
pLK4 (592) pESC-URA-GAL10PR-Cox12K36-FLAG This study
pLK5 (593) pESC-URA-GAL10PR-Cox12K41-FLAG This study
pPB33 (468) pESC-URA-GAL10PR-Cox12K73-FLAG This study
pRS415 pRS415 [101]
pPB19.1 (200) p415-GDPPR-mCherry-sfGFP This study
pPB20.1 (201) p415-GDPPR-Cox12-mCherry-sfGFP This study
pPB24.1 (385) p415-GDPPR-Cox12C-FREE-mCherry-sfGFP This study
pPB30.1 (391) p415-GDPPR-Cox17-mCherry-sfGFP This study
pPB21.1 (202) p415-GDPPR-Pet191-mCherry-sfGFP This study
pPB25.1 (386) p415-GDPPR-Tim9-mCherry-sfGFP This study
pPB28.1 (389) p415-GDPPR-Tim10-mCherry-sfGFP This study
pMaM98 (158) p415-GDPPR-Ubi-I-mCherry-sfGFP [51]
pMaM99 (159) p415-GDPPR-Ubi-M-mCherry-sfGFP [51]
pMaM100 (160) p415-GDPPR-Ubi-F-mCherry-sfGFP [51]
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simultaneously carried a tFT-tagged protein and a
genetic perturbation were performed by sequential
pinning on appropriate selective media using pinning
robots (BioMatrix, S&P Robotics) as described previ-
ously [92], followed by seamless marker excision [93].
Fluorescence intensities of the final colonies were
measured in the mCherry channel (587/10 nm excita-
tion, 610/10 nm emission) and sfGFP channel (488/
10 nm excitation, 510/10 nm emission) after 24 h of
growth on synthetic complete medium that lacked
histidine at 30 °C using an Infinite M1000 or Infinite
M1000 Pro plate reader equipped with stackers for
automated plate loading (Tecan) and custom
temperature control chambers.
Measurements were filtered for potentially failed crosses
based on colony size after haploid selection. Fluorescence
intensity measurements were log-transformed and cor-
rected for spatial effects on plates by local regression.
Median effects for tFT and deletion strains were sub-
tracted from log-ratios of mCherry and sfGFP intensities.
Standard deviations were regressed against the absolute
fluorescence intensities. Changes in protein stability were
divided by the regressed standard deviations, yielding a
measurement comparable to a z-score, and tested
against the hypothesis of zero change. p values were
calculated using a moderated t test (R/Bioconductor
package limma) and adjusted for multiple testing
using the Benjamini-Hochberg method.
Measurements of fluorescent signals in liquid culture
Wild-type yeast were transformed with plasmids that
allowed the constitutive expression of tFT fusions and
were grown in liquid selective media. The fluorescence
intensities of mCherry and sfGFP proteins of the tFT
were measured using an Infinite M1000 plate fluorim-
eter (Tecan) in 96-well plates directly from the culture.
Cultures of yeast with an empty vector were used to
correct for background fluorescence. Data were acquired
using Magellan software (Tecan). All of the calculations
were performed using Microsoft Excel software.
Confocal microscopy
The acquisition of confocal images of live yeast cells was
performed using a Zeiss LSM800 confocal microscope with
a 63× 1.4 oil immersion objective and ZEN 2.3 software
(Zeiss). Yeast that expressed selected IMS proteins that
were tagged with tFT were grown in minimal synthetic
media with glycerol as a main carbon source at 24 °C. Prior
to imaging, growth media were supplemented with Mito-
Tracker Deep Red FM (200 nM, Thermo Scientific) and
Calcofluor White M2R (5 μg/ml, Sigma), followed by
10 min of incubation. For imaging, the samples were placed
on poly-L-lysine-coated glass slides (Sigma). The acquisition
settings were adjusted for each experimental condition for
maximum intensity projections. Sixteen-bit images with a
resolution of 358 × 358 pixels were acquired, exported to
Adobe Photoshop software with adjustments of contrast
and brightness, and assembled in Adobe Illustrator
software.
Homology modeling
The homology modeling of S. cerevisiae Tom40 was per-
formed with the template of the Neurospora crassa Tom40
structure PDB:5O8O [67]. To align the sequences,
MUSCLE alignment software was used [94]. The homology
model was created with Modeller software [95]. The image
was generated using Chimera software [96].
Miscellaneous
Gene and protein names are used in accordance with the
Saccharomyces Genome Database. Total protein cell ex-
tracts were made using the alkaline lysis protocol (adapted
from Yaffe and Schatz) or by disrupting the cells with glass
beads in the presence of precipitating agent (TCA) as de-
scribed previously [97, 98]. Samples were denatured in 2×
Laemmli buffer with 100 mM DTTat 65 °C. Samples were
analyzed by SDS-PAGE followed by Western blot. The
antibodies that were used for immunodetection were
raised in rabbits and verified for specificity, with the ex-
ception of commercial mouse monoclonal anti-ubiquitin
antibody (P4D1; Santa Cruz Biotechnology Cat# sc-8017,
RRID:AB_628423; 1:500 dilution) and anti-FLAG M2
(Sigma-Aldrich Cat# F1804, RRID:AB_262044, 1:500 dilu-
tion) antibodies. The chemiluminescent signals were de-
tected using X-ray films or an ImageQuant LAS4010
instrument (GE Healthcare). For Cox12FLAG and its deriv-
atives, we frequently detect additional band with altered
slower migration speed. This additional band is specific to
Cox12FLAG protein as it can be detected both with
anti-Cox12 and anti-FLAG antibodies. The additional
band can be detected also in case of Cox12 variants with-
out cysteine residues (Cox12C-FREE-FLAG) or without lysine
residues (Cox12K-FREE-FLAG). For quantification of West-
ern blot and autoradiography results, densitometry was
performed using ImageQuant TL (GE Healthcare), and
calculations were performed using Microsoft Excel soft-
ware. The results of the quantifications are presented as
mean from an indicated number of replicates (n). For n <
6 individual data points are provided in Additional file 2:
Table S2. Error bars represent the standard error of the
mean (SEM). Images were processed with Adobe Photo-
shop software and assembled into figures using Adobe Il-
lustrator software. To identify highly evolutionarily
conserved amino acid residues in S. cerevisiae Cox12 pro-
tein, the alignment of Cox12 sequences from 235 related
fungi was performed using Clustal Omega [99]. Sequences
that introduced gaps into the alignment were excluded.
The data were visualized using WebLogo [100].
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Additional files
Additional file 1: Table S1. Results of screens for machinery involved in
the degradation of IMS proteins. Changes in protein stability, represented
as a z-score and corresponding p values, are provided for all combinations
of the tested tFT-tagged IMS proteins and mutants of components of the
ubiquitin-proteasome system. NA, not available. (XLSX 114 kb)
Additional file 2: Table S2. Individual data points for quantifications
presented on Figs. 5a and 6c–e. Individual data points that were used for
the preparation of the graphs. Sample names are as on corresponding
figures. (XLSX 11 kb)
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